Screener
Protagonist Therapeutics PTGX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities - noncurrent | 66,875 | 78,638 |
| Property and equipment, net | 3,456 | 3,860 |
| Restricted cash - noncurrent | 287 | 287 |
| Operating lease right-of-use asset | 6,946 | 7,829 |
| Other non-current asset | 832 | — |
| Total assets | $885,544 | $668,188 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's operating lease ROU assets?
- Protagonist Therapeutics (PTGX) reported operating lease ROU assets of $6.95M in Q2 2026.
- How has Protagonist Therapeutics's operating lease ROU assets changed year-over-year?
- Protagonist Therapeutics's operating lease ROU assets decreased by 19.1% year-over-year, from $8.59M to $6.95M.
- What is the long-term trend for Protagonist Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's operating lease ROU assets has grown at a 9.6% compound annual growth rate (CAGR), from $4.95M to $7.83M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Protagonist Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude